A top-20 shareholder in Santos has raised questions about the oil and gas producer’s strategy and called for it to focus on delivering value to investors, just as the gas giant was forced to cut ...

NICE is unable to make a recommendation about the use in the NHS of vepdegestrant for treating hormone receptor-positive HER2-negative metastatic breast cancer after endocrine treatment. This is ...

Management updated its outlook, anticipating full year MIS revenue growth in the high single-digit range, an upward revision from the previous outlook. Heuland stated, "We now expect MCO revenue to ...

The 2024 voluntary scheme for branded medicines, pricing, access and growth states that NICE will continue to evaluate all new active substances and significant indications, except where there is a ...

Learn how to invest in stocks, including how to select a brokerage account and research stock market investments. Many, or all, of the products featured on this page are from our advertising partners ...

Rogers delivers industry-leading combined mobile phone and Internet net additions, best wireless customer loyalty in over two years, strong Wireless and Cable margins, and healthy revenue growth from ...